The challenge of defining “ultra-high-risk” neuroblastoma-Reference-Cited by-同舟云学术

The challenge of defining “ultra-high-risk” neuroblastoma

Published:2018-11-26 Issue:4 Volume:66 Page:e27556
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Morgenstern Daniel A.¹^ORCID,Bagatell Rochelle²,Cohn Susan L.³,Hogarty Michael D.²,Maris John M.²,Moreno Lucas⁴^ORCID,Park Julie R.⁵,Pearson Andrew D.⁶,Schleiermacher Gudrun⁷,Valteau-Couanet Dominique⁸,London Wendy B.⁹,Irwin Meredith S.¹^ORCID

Affiliation:

1. Hospital for Sick Children and University of Toronto; Toronto Canada

2. Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine; Philadelphia Pennsylvania

3. University of Chicago; Chicago Illinois

4. Hospital Universitario Niño Jesus; Madrid Spain

5. Seattle Children's Hospital and University of Washington School of Medicine; Seattle Washington

6. Institute of Cancer Research and Royal Marsden National Health Service (NHS) Foundation Trust; Sutton Surrey UK

7. Institut Curie; Paris France

8. Gustave Roussy; Villejuif France

9. Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Harvard Medical School; Boston Massachusetts

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.27556/fullpdf

Reference76 articles.

1. Neuroblastoma;Maris;Lancet,2007

2. The International Neuroblastoma Risk Group (INRG) classification system: an INRG task force report;Cohn;J Clin Oncol,2009

3. Park JR Bagatell R Cohn SL Revisions to the international neuroblastoma response criteria: a consensus statement from the National Cancer Institute Clinical Trials Planning Meeting 2017 35 2580 2587 https://doi.org/10.1200/JCO.2016.72.0177

4. Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission;Cheung;J Clin Oncol,2012

5. Prolonged isotretinoin in ultra high-risk neuroblastoma;Cash;J Pediatr Hematol Oncol,2017

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RT-PCR demonstrates superior sensitivity and specificity in detecting the five neuroblastoma genes compared to the flow cytometry method for measurable residual disease;Translational Pediatrics;2023-12

2. RTEL1 gene polymorphisms and neuroblastoma risk in Chinese children;BMC Cancer;2023-11-24

3. Integrating bulk-seq and single-cell-seq reveals disulfidptosis potential index associating with neuroblastoma prognosis and immune infiltration;Journal of Cancer Research and Clinical Oncology;2023-09-15

4. Identification of an Ultra-High-Risk Subgroup of Neuroblastoma Patients within the High-Risk Cohort Using a Computed Tomography-Based Radiomics Approach;Academic Radiology;2023-09

5. Development and validation of a nomogram based on common biochemical indicators for survival prediction of children with high-risk neuroblastoma: A valuable tool for resource-limited hospitals;BMC Pediatrics;2023-08-26